Log in
Back to #small language model
#small language model Open access

Using multimodal foundational models to predict neoantigen immunogenicity and vaccine effectiveness across different tumor types

Gang Liu Jia Wang Jia Zhu
Aug 2026 · Global Health Care · 0 citations · 21 references

TL;DR

This work is the first to use a multi-modal foundation model for neoantigen vaccines, overcoming the tumor-type-specific constraints of conventional approaches and facilitating joint modelling of immunogenicity and clinical efficacy, thereby offering an AI decision engine for precision cancer vaccine design that is applicable to all cancer types.

Abstract

Neoantigen vaccines are a key component of personalised cancer immunotherapy; however, existing prediction techniques are primarily restricted to a single tumour type and have difficulty integrating multi-modal biological data, which leads to inadequate accuracy in immunogenicity evaluation and vaccine efficacy prediction. In order to predict neoantigen immunogenicity and customised vaccination clinical outcomes across various tumour types, this study attempts to develop and verify a universal multi-modal foundation model.Neoantigen peptide sequences, mass spectrometry-derived pHLA binding patterns, single-cell TCR repertoires, tumour transcriptomes, and clinical vaccination trial follow-up records were among the extensive paired data we gathered from 15 solid tumour types. We present the NeoVAX-FM multi-modal foundation model, which first embeds peptide sequences, pHLA complex 3D structures, and gene expression into a single semantic space using a contrastive language-image pretraining paradigm. It is then fine-tuned on downstream tasks to concurrently score immunogenicity and predict progression-free survival.The model was assessed in one prospective clinical trial and three external validation cohorts. NeoVAX-FM showed strong performance in melanoma, non-small cell lung cancer, and microsatellite stable colorectal cancer, with an average AUC of 0.94 for cross-tumor neoantigen immunogenicity prediction—a 12.3% increase over the best currently available techniques. Patients in the prospective vaccination cohort who were projected by the model to be “high responders” had a considerably higher median progression-free survival (HR = 0.28, p < 0.001), and the model was successful in identifying tumour microenvironment characteristics and universal TCR motifs that drive long-term responses.This work is the first to use a multi-modal foundation model for neoantigen vaccines, overcoming the tumor-type-specific constraints of conventional approaches and facilitating joint modelling of immunogenicity and clinical efficacy, thereby offering an AI decision engine for precision cancer vaccine design that is applicable to all cancer types.

DOI Semantic Scholar
Read PDF

Similar papers

#small language model Open access Aug 2026

LifeSciBench: Evaluating Language Models on Realistic, Expert-Level Tasks in the Life Sciences

LifeSciBench is introduced, a benchmark of 750 expert-authored tasks designed to evaluate whether language models can handle realistic life science research work, with each constituent task paired with a human expert-written rubric.

Amelia Liu, Andrew Ho, Anne Marie Droste et al. · 2 citations
#artificial intelligence Preprint Aug 2026

TestifAI: Tomography-Based Testing for Deep Learning Systems

TestifAI, a deep learning testing framework for efficient and accurate estimation of robustness against combinations of perturbations, is proposed and partial model tomography is introduced, a novel approach to reconstructing model behaviour in a multi-perturbation space from tests that apply only a small number of perturbations.

Arooj Arif, T. Hartung, E. Botoeva et al. · 1 citation
#small language model Review Open access Sep 2026

SYNGAP1-related disorder: pathophysiology, epilepsy, cognitive and behavioral phenotypes, and precision therapeutic approaches.

A rapidly advancing precision-therapy pipeline-including antisense oligonucleotides to upregulate the intact allele, AAV-based gene replacement, CRISPR-mediated transcriptional activation, epigenetic modulators, and rational pathway-targeted small molecules-offers realistic prospects for disease modification.

Debopam Samanta · 1 citation
#small language model Preprint Aug 2026

The Evaluation Context Protocol (ECP): A Portable Contract for AI Agent Evaluation

This paper proposes the Evaluation Context Protocol (ECP), an early-stage, vendor-neutral framework intended to act as a portable evaluation contract layer for agentic systems and describes an open-source reference implementation that includes adapters for LangChain, LlamaIndex, CrewAI, and PydanticAI.

Aniket Wattamwar, Manav Anandani, Mrunal Kakirwar · 0 citations
#small language model Review Aug 2026

Large Language Models in Oral and Maxillofacial Surgery Triage: A Scoping Review

Large Language Models show potential in their diagnostic accuracy and consequent ability to reduce clinician burden, and may provide the greatest benefit when used to optimise referral quality at source, improving both clinician and potentially LLM triage downstream.

K. Surendran, I. Aziz, Glyndwr Jenkins · 0 citations
#small language model Review Open access Aug 2026

Quality, consistency, and clinical safety of AI-generated versus clinician-written clinical notes: a multi-country paired simulation study

Background Ambient AI documentation tools, known as scribes, are entering routine clinical practice at scale, but the evidence comparing the notes they produce against clinician-written notes is dominated by single-site, single-language studies that rely on human review to find errors, a method known to miss most documentation errors. Methods We conducted a paired simulation across five countries and languages (Cambridge/English, Barcelona/Spanish, Milan/Italian, Paris/French, Cologne/German; 385 paired consultations, 770 notes). From each actor-performed consultation, an AI scribe (Heidi) and a junior-to-middle-grade clinician independently produced a note. Notes were scored on the PDQI-9 by evaluators blinded to authorship. Documentation errors were identified by two methods of deliberately different sensitivity - clinician adjudication, and a calibrated automated reviewer externally validated against a blinded ten-clinician panel - then graded for clinical risk by a three-model panel. The co-primary outcomes were PDQI-9 total and Critical+High error burden, the latter reported under both detection arms. The analysis plan was registered before any pooling across sites. Results AI notes scored higher than clinician notes on the PDQI-9 (40.6 vs 35.6; difference +5.08, 95% CI 4.6-5.6; Cohen dz=0.55), consistently across all five sites (dz 0.41-0.75), and were less dispersed (5.7% of AI vs 27.8% of clinician notes fell below the study pre-specified low-score threshold (<32)). On the principal safety outcome - the paired probability that a note carried [≥]Critical+High error - clinician notes were affected more often under both detection arms: 61.0% versus 24.4% by the calibrated reviewer (relative risk 2.50, 95% CI 2.09-3.00) and 21.8% versus 6.2% by clinician adjudication (relative risk 3.50, 95% CI 2.32-5.27). The difference was largest for omissions. Unaided clinician review identified roughly 12% of the errors the calibrated reviewer retained, and a smaller fraction in AI notes than in clinician notes. Conclusions In this simulation, AI-generated notes scored higher on documentation quality, varied less, and carried fewer clinically significant errors than notes written on the same consultations by junior-to-middle-grade clinicians. The magnitude of the safety difference depends on the sensitivity of error detection, so we report both detection regimes and bound rather than point-estimate the absolute error rate. Extension to live practice, consultant-authored documentation, and notes as filed after clinician editing remains to be established.

H. Bergman, V. Liu, B. Austin et al. · 0 citations

Related blog posts